Patents by Inventor Regina Flinn Peacock

Regina Flinn Peacock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for reducing ocular hypertension
    Patent number: 6770675
    Abstract: An improved ophthalmic composition, including docosanoid active agents, which is especially useful in lowering intraocular pressure associated with glaucoma. Improvements in IOP reduction efficacy, preservative efficacy and reduced additive concentrations are achieved by utilizing the disclosed compositions which include a docosanoid active agent (e.g., isopropyl unoprostone), in conjunction with selected non-ionic surfactants, preservatives, and non-ionic tonicity adjusting agents.
    Type: Grant
    Filed: March 19, 2001
    Date of Patent: August 3, 2004
    Assignee: Novartis AG
    Inventors: Kenneth Warren Reed, Shau Fong Yen, Mary Sou, Regina Flinn Peacock
  • Compositions and methods for reducing ocular hypertension
    Publication number: 20020002185
    Abstract: An improved ophthalmic composition, including docosanoid active agents, which is especially useful in lowering intraocular pressure associated with glaucoma. Improvements in IOP reduction efficacy, preservative efficacy and reduced additive concentrations are achieved by utilizing the disclosed compositions which include a docosanoid active agent (e.g., isopropyl unoprostone), in conjunction with selected non-ionic surfactants, preservatives, and non-ionic tonicity adjusting agents.
    Type: Application
    Filed: March 19, 2001
    Publication date: January 3, 2002
    Inventors: Kenneth Warren Reed, Shau Fong Yen, Mary Sou, Regina Flinn Peacock